معرفی
Edmond Kwan is a Senior Research Fellow and Laboratory Head at Eastern Health Clinical School, Monash University, with a cross-appointment in the Biomedicine Discovery Institute's Prostate Cancer Research Group. He is also a clinician-scientist and genitourinary cancer medical oncologist at Eastern Health, Melbourne. Kwan holds dual expertise in prostate cancer genomics and clinical oncology, focusing on developing biomarkers (tissue/ctDNA) to predict treatment outcomes in metastatic prostate cancer. His work integrates molecular biology, bioinformatics, and clinical trials to guide precision medicine strategies.
Education & Career:
- PhD in Prostate Cancer Genomics (Monash University)
- Postdoctoral Fellowship at Vancouver Prostate Centre (2017–2024)
- Genitourinary Clinical Fellowship at BC Cancer, Canada
- Returned to Australia in 2024 to establish independent research
Research Interests: Prostate cancer genomics, ctDNA biomarkers, precision medicine, biobanking, and translational oncology. His team explores genomic/epigenomic alterations in tumor tissue and blood to improve therapeutic decision-making.
Key Projects:
- TheraP Trial (Phase 2 trial comparing Lu-PSMA-617 with cabazitaxel)
- ICE-PAC Trial (Avelumab + SABR for mCRPC)
- Monash Cancer Donor Program (Biobanking initiatives)
Grants & Collaborations: Principal Investigator on multiple ANZUP-funded projects (e.g., immune checkpoint inhibitor biomarker studies, PARP inhibitor trials). Collaborates with institutions in Australia, Canada, and internationally on genomic profiling and clinical trials.
Labs/Teams: Leads the Prostate Cancer Research Group at Monash, focusing on integrative oncology research and clinical genomics.
